Global medical technology company Implanet saw a 58 percent increase in revenue in 2021, the company said Jan. 18.
The company saw a 60 percent increase in revenue during the fourth quarter of 2021 compared to the fourth quarter of 2020.
Implanet saw growth in its spine business, although it noted that activity in the U.S. was heavily affected by COVID-19. U.S. revenue declined 20 percent.
The company said it plans to finalize the globalization of its spine surgery products in 2022 while strengthening its presence in the U.S. and seeking more partnerships.